Agios Pharmaceuticals (8AP.MU) Q2 2026 Earnings

29AprConfirmed
Q1 2026
Q2 2026
-1.65
-1.58
-1.51
-1.45

Details

Expected EPS
-1.54421278316
Actual EPS
-1.4471132
Surprise EPS
0.1
Surprise Percent
+6.29%

Description

Agios Pharmaceuticals (8AP.MU) has reported earnings of -1.4471132 per share for Q2 2026.

0 Comments

Share your thoughts